Rune Labs Secures FDA Clearance
SAN FRANCISCO, June 13, 2022 /PRNewswire/ -- Rune Labs, a precision neurology company, announced its StrivePD software ecosystem for Parkinson's disease has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) to collect patient symptom data through measurements made by Apple Watch. By combining powerful wearable technology and self-reported symptom information with brain imaging, electrophysiology, genetic and other clinical data, StrivePD enables a data-driven approach to care management and clinical trial design for Parkinson's.